Correction: Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex

Correction for ‘Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex’ by Dorothea Helmer et al., RSC Adv., 2015, 5, 25657–25668.
The authors regret that the original article included some results which were subsequently found to be based on a slightly different peptide sequence than the sequence originally reported. This issue is addressed in the following text, which is an update to the original article.
Upon further investigation of the IL8 capture peptide IL8-RP-Loops introduced in the original article, we found that during synthesis of the intended peptide sequence AKWRMVLRI–Ahx–ADTLMRTQ we had obtained the peptide AKWRMVLRI–Ahx–ADTLMRTE, in which the C-terminal glutamine was replaced with glutamic acid. This was confirmed by high resolution mass spectrometry. The reported high affinity (0.5 ± 0.3 μM) was reproduced by the E-mutant within experimental error (1.1 ± 0.1 μM) but not for the original sequence ending with glutamine. We conclude that all experiments were performed with the peptide AKWRMVLRI–Ahx–ADTLMRTE.
The affected amino acid Q271 was shown to be non-essential for receptor function by Hébert et al.1 So no essential amino acid of the original sequence was omitted in the exchange.
... mehr
In the original publication we claimed that preorganization of the peptide is responsible for the high affinity of the receptor-derived peptide, as CD-spectroscopy had revealed a helical structure for the synthesized peptide. To test the effect of the exchange of glutamine with the structurally closely related glutamic acid on the preorganization of the peptide in solution, we ran a new set of molecular dynamics simulations on the peptide containing the original receptor sequence and the actually synthesized peptide IL8-RP-Loops. The helical content of the peptide structure over the course of the simulation was higher for IL8-RP-Loops with C-terminal glutamic acid (23.6%) than for the peptide ending with glutamine (6.0%). Thus, the serendipitous exchange of the polar glutamine at the C-terminus with negatively charged glutamic acid enhanced preorganization and led to the capture peptide with high affinity.
In conclusion, a capture peptide could be designed based on a binding region identified from a computational model of the CXCL8:CXCR1 complex. The peptide comprises receptor residues known to form essential contacts with the chemokine ligand and the exchange of the non-essential C-terminal glutamine for glutamic acid enhances the preorganization into a partially helical structure in solution responsible for its high affinity to the chemokine. In the design of receptor-derived capture peptides it is therefore important to examine the propensity to form secondary structure elements in solution to obtain high affinity peptide mimetics.